Novel splice site variants in GBA1 are associated with Gaucher disease and genotype-phenotype correlations.
This study identified compound heterozygous GBA1 variants, including two novel candidate pathogenic splice site variants, in Gaucher disease type 3 patients, expanding the known mutational spectrum.